AIM:This study aimed to assess the cost-utility of luseogliflozin compared with Standard of Care (SoC) for patients with T2DM in Vietnam, under two reimbursement scenarios by Vietnam Social Health Insurance (VSHI). METHODS:A Markov model with five health states was developed to simulate lifetime disease progression. The analysis adopted the VSHI perspective, including only direct medical costs. Health outcomes were expressed as quality-adjusted life-years (QALYs), and cost-effectiveness was evaluated against a willingness-to-pay (WTP) threshold of 1 GDP per capita in Vietnam (USD 4,700 per QALY). Both costs and outcomes were discounted at 3% annually. One-way and probabilistic sensitivity analyses (10,000 iterations), as well as a scenario analysis reflecting the 70% reimbursement case (consistent with the reimbursement rate applied to other SGLT2 inhibitors) were conducted. RESULTS:In the base case (100% reimbursement), luseogliflozin increased total costs by USD 535.38 and yielded 0.325 additional QALYs, resulting in an incremental cost-effectiveness ratio (ICER) of USD 1,649.34/QALY, which is well below the WTP used in this analysis. The probabilistic analysis showed a mean ICER of USD 1,661/QALY, with 100% of simulations confirming cost-effectiveness. In the 70% reimbursement scenario, the incremental cost decreased to USD 327.74, yielding an ICER of USD 1,010/QALY, further strengthening the conclusion of cost-effectiveness. CONCLUSION:From the VSHI perspective, luseogliflozin was cost-effective compared with SoC, and the results remained robust across all sensitivity and scenario analyses. As the first economic evaluation of luseogliflozin in Vietnam, these findings provide locally relevant evidence to inform reimbursement policy for diabetes treatment.
Introduction: Economic development leads to higher life expectancy, and in most countries is also associated with a higher level of alcohol consumption, as more people start to consume alcohol. As alcohol consumption is a major risk factor for many diseases, this increased consumption of alcohol reduces life expectancy, and in turn slows down economic development. However, alcohol control policies may reduce consumption and mitigate the detrimental effects of alcohol use on life expectancy and the economy. The objectives of this study are to quantify the interrelations between alcohol control policies, levels and patterns of consumption, life expectancy, and economic development for the Association of South East Asian Nations (ASEAN) countries between 2000 and 2023. Methods and analysis: Secondary data analysis of available data will be undertaken, using a cross-sectionally correlated and time-wise autoregressive model for the main conceptual model. In addition, the detrimental effects of alcohol consumption on economic development will be estimated directly and indirectly via its effect on health indicators. Ethics and Dissemination: As a secondary analysis study of publicly available data, this research does not require approval by a research ethics board. Its results will be disseminated via peer-reviewed publications, webinars, and other forms available to decision-makers. Strengths and limitations: We selected a region, the ASEAN countries, which experienced high growth in economic growth wealth as measured by increases in per capita Gross Domestic Product in Purchasing Power Parity since the turn of the century. We were able to use standardized comparable data from international agencies (World Bank, World Health Organization). The study is based on a on a strong conceptual model; i.e., the framework of Angus Deaton, expanded to include the impact of alcohol. We have sufficient data points available to conduct the cross-sectionally correlated and time-wise autoregressive model. However, there may be difficulties in modeling feedback loops within a system in which a change in one variable can eventually lead back to affect the original variable. Finally, there are important potential practical implications for health policy.
Background: Malaria continues to pose a major public health threat globally, affecting millions and causing numerous fatalities annually. This research consolidates findings on private sector healthcare involvement in combating and preventing malaria across different nations. Methodology: A systematic review was conducted following PRISMA guidelines, extracting relevant studies from PubMed, ScienceDirect, Cochrane, and Semantic Scholar databases. Selection criteria included observational or interventional research examining private healthcare's role in malaria prevention, published in English between 2015-2024. Analysis was supported by NotebookLM. Results: The review identified 24 qualifying studies. Private healthcare providers, including clinics and pharmacies, contribute to malaria management through diagnosis, rapid testing, and treatment advice globally. Though these entities possess some malaria-related knowledge, it remains incomplete. Case reporting and surveillance participation exists among private providers but remains restricted to few facilities. Conclusions: Enhanced frameworks and regulations are essential to strengthen public-private partnerships and expand private sector engagement in malaria diagnosis, treatment, and advisory services. Implementation strategies should be tailored to each country's specific context and malaria epidemiology.
Background. Regular blood donation plays a pivotal role in mitigating the formation of free radicals by regulating iron accumulation. However, frequent blood donation can lead to chronic iron deficiency. In this study, we aimed to evaluate the effectiveness of daily iron supplementation as an intervention to expedite hemoglobin (Hb) recovery among frequent blood donors at a hospital in Vietnam. Methodology. Conducted longitudinally within the Hematology Department of a Hanoi hospital from February to July 2023, our study involved 104 eligible participants. They received a daily iron supplement comprising 100 mg of elemental iron, 0.75 mg of folic acid, and 5 mg of zinc sulfate for a minimum of 8 weeks. Blood samples were collected at three key time points: before blood donation during recruitment, immediately after donation, and at least 8 weeks post-donation. Results. Our findings revealed moderate, statistically significant positive correlations between elemental iron administration and changes in platelet count (PLT), hematocrit (HCT), and mean corpuscular hemoglobin (MCH) (r = 0.753, p <0.001; r = 0.887, p <0.001; and r = 0.703, p <0.001, respectively). Additionally, weak but significant correlations were observed between elemental iron administration and red blood cell count (RBC), mean corpuscular volume (MCV), mean corpuscular hemoglobin concentration (MCHC), red cell distribution width coefficient of variation (RDWC), and red cell distribution width standard deviation (RDWS) (r = 0.260, p = 0.002; r = 0.302, p = 0.005; r = 0.160, p = 0.010; r = 0.120, p = 0.020; and r = 0.400, p <0.001, respectively). Conclusion. Over an eight-week duration, the regimen of daily iron supplementation yielded significant improvements in both red cell variables, red cell indices, and iron study variables, demonstrating its potential clinical impact.
Objective: Telehealth has become essential in healthcare delivery, particularly during the COVID-19 pandemic. It provides solutions to access disruptions and enhances healthcare accessibility and efficiency. This study aimed to describe the utilization, demand, and willingness to pay for Telehealth services in selected provinces in Vietnam. Methods: A cross-sectional survey involving 438 participants from three Vietnamese provinces was conducted between late 2021 and early 2022. The study assessed telehealth utilization, user preferences, and willingness to pay for different telehealth services. Results: The study revealed that 58.7% of participants had utilized telehealth services. For lower-cost services (100,000 VND to 500,000 VND), low-income households were 2.7 times more likely to pay (OR: 2.7, 95% CI: 1.41-5.00, p<0.01); familiarity with telehealth services increased the likelihood of spending by 1.6 times (OR: 1.6, 95% CI: 1.10-2.54, p<0.05); and those with less convenient access to healthcare were 1.79 times more likely to pay (OR: 1.79, 95% CI: 1.00-3.13, p<0.05). For higher-cost services (500,000 VND to 1,500,000 VND), wealthier households were 16.67 times more likely to invest (OR: 16.67, 95% CI: 2.04-100.00, p<0.01); insured individuals were 5.88 times more likely to pay (OR: 5.88, 95% CI: 1.92-16.67, p<0.01); and familiarity with telehealth increased the likelihood of payment by 2.3 times (OR: 2.3, 95% CI: 1.20-4.46, p<0.05). Conclusion: Telehealth is a crucial component of healthcare in Vietnam, with substantial engagement and willingness to pay. The findings underscore the need for investment in telehealth infrastructure and supportive policies to integrate telehealth into the national healthcare system, particularly in underserved regions.